Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Biology & Therapy|January 11, 2005
Immunomodulation of multiple myelomaTanyifor M Tohnya, William D FiggCancer Biology & Therapy|August 27, 2005
Cyclooxygenase-2 and angiogenesis in prostate cancerVictoria L Tkacz, Tanyifor M Tohnya, William D FiggJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Determination of SU5416, a novel angiogenesis inhibitor, in human plasma by liquid chromatographyTanyifor M Tohnya, Sonia Kim, Howard A Fine, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 4, 2004
Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometryTanyifor M Tohnya, Kyunghwa Hwang, Erin R Lepper, et al.Journal of Clinical Pharmacology|May 20, 2009
Phase I study of oral lenalidomide in patients with refractory metastatic cancerWilliam L Dahut, Jeanny B Aragon-Ching, Sukyung Woo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignanciesD Ross Camidge, Roy S Herbst, Michael S Gordon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancerRoy S Herbst, S Gail Eckhardt, Razelle Kurzrock, et al.Pageof 1